Dactolisib is an imidazoquinoline compound that functions as a dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and mTOR. It has been investigated as an antineoplastic agent in cancer research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Dactolisib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Flurbiprofen axetil
pharmaceutical raw material
(R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
pharmaceutical raw material
Enzalutamide
pharmaceutical raw material
Telmisartan amide
pharmaceutical raw material
The international HS code for Dactolisib (CAS 915019-65-7) is 2933.49.
2933.49
2933 49 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c]quinolin-1-yl)phenyl]propanenitrile
JOGKUKXHTYWRGZ-UHFFFAOYSA-N
CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5
Sourcing Dactolisib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.